Andrew Reardon - Net Worth and Insider Trading
Andrew Reardon Net Worth
The estimated net worth of Andrew Reardon is at least $4 Million dollars as of 2025-07-24. Andrew Reardon is the CLO & Secretary of Ligand Pharmaceuticals Inc and owns about 31,903 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $4 Million. Details can be seen in Andrew Reardon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Reardon has not made any transactions after 2025-06-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Reardon
Andrew Reardon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Reardon owns 1 companies in total, including Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of Andrew Reardon’s form 4 insider trades.
Insider Ownership Summary of Andrew Reardon
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2025-06-23 | CHIEF LEGAL OFFICER & |
Andrew Reardon Latest Holdings Summary
Andrew Reardon currently owns a total of 1 stock. Andrew Reardon owns 31,903 shares of Ligand Pharmaceuticals Inc (LGND) as of June 23, 2025, with a value of $4 Million.
Latest Holdings of Andrew Reardon
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2025-06-23 | 31,903 | 136.21 | 4,345,508 |
Holding Weightings of Andrew Reardon
Andrew Reardon Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Reardon has made a total of 7 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 500 shares on June 23, 2025, which brought Andrew Reardon around $57,040.
Insider Trading History of Andrew Reardon
- 1
Andrew Reardon Trading Performance
Andrew Reardon Ownership Network
Ownership Network List of Andrew Reardon
Ownership Network Relation of Andrew Reardon
Andrew Reardon Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Andrew Reardon is the CHIEF LEGAL OFFICER & of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , VP & Finance and CFO Matthew E Korenberg , and CEO & President John L Higgins .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Andrew Reardon made 6 insider transaction in Ligand Pharmaceuticals Inc (LGND) with a net sale of 15,500. Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 20,312 shares made by Octavio Espinoza , a net sale of 70,748 shares made by Matthew E Korenberg , and a net purchase of 12,010 shares made by Todd C Davis .
In summary, during the past 3 months, insiders sold 2,934 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 11,010 shares, with a net purchase of 8,076 shares. During the past 18 months, 114,227 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 13,510 shares were bought by its insiders, resulting in a net sale of 100,717 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Andrew Reardon Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Reardon. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Andrew Reardon's mailing address is: San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
